Quince Therapeutics Stock (NASDAQ:QNCX), Quotes and News Summary

Q: What sector and industry does Quince Therapeutics (QNCX) operate in?

Quince Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Quince Therapeutics Stock (NASDAQ: QNCX) stock price, news, charts, stock research, profile.

Open	$1.050
Close	$1.070
Volume / Avg.	96.565K / 71.755K
Day Range	1.050 - 1.120
52 Wk Range	0.840 - 1.740
Market Cap	$43.215M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	4.65%
Days to Cover	49.76

Recent News

SHF Holdings And 3 Other Stocks Under $2 Insiders Are Buying

The Dow Jones closed higher by over 60 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Avi Kapoor

Over $2M Bet On This Industrial Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed higher by around 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket

Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Quince Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovati...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Quince Therapeutics (QNCX) stock?

You can purchase shares of Quince Therapeutics (NASDAQ: QNCX) through any online brokerage.

View our list of the best stock brokerages.

Who are Quince Therapeutics's (QNCX) competitors?

Other companies in Quince Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Eagle Pharmaceuticals (NASDAQ:EGRX) and Bolt Biotherapeutics (NASDAQ:BOLT).

What is the target price for Quince Therapeutics (QNCX) stock?

There is no analysis for Quince Therapeutics.

Current Stock Price for Quince Therapeutics (QNCX)?

The stock price for Quince Therapeutics (NASDAQ: QNCX) is $1 last updated April 26, 2024 at 6:08 PM EDT.

Does Quince Therapeutics (QNCX) pay a dividend?

There are no upcoming dividends for Quince Therapeutics.

When is Quince Therapeutics (NASDAQ:QNCX) reporting earnings?

Quince Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Quince Therapeutics (QNCX) going to split?

There is no upcoming split for Quince Therapeutics.

What sector and industry does Quince Therapeutics (QNCX) operate in?

Quince Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-